OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 26
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Causal association of plasma circulating metabolites with nephritis: a Mendelian randomization study
Fengling Shao, Yingling Yao, Dunchu Weng, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 8
Fengling Shao, Yingling Yao, Dunchu Weng, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 8
Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway
Liu Li, Junju Zou, Hui Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117008-117008
Open Access | Times Cited: 8
Liu Li, Junju Zou, Hui Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117008-117008
Open Access | Times Cited: 8
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease
Nejc Piko, Sebastjan Bevc, Radovan Hojs, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 418-418
Open Access | Times Cited: 6
Nejc Piko, Sebastjan Bevc, Radovan Hojs, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 418-418
Open Access | Times Cited: 6
Kidney tea [Orthosiphon aristatus (Blume) Miq.] improves diabetic nephropathy via regulating gut microbiota and ferroptosis
Zheng Zhou, Hongjuan Niu, Meng Bian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Zheng Zhou, Hongjuan Niu, Meng Bian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Causal relationship between gut microbiota and autoimmune thyroiditis: A mendelian study
Yujun Xiong, Xingyun Zhu, Qingfeng Luo
Heliyon (2024) Vol. 10, Iss. 3, pp. e25652-e25652
Open Access | Times Cited: 5
Yujun Xiong, Xingyun Zhu, Qingfeng Luo
Heliyon (2024) Vol. 10, Iss. 3, pp. e25652-e25652
Open Access | Times Cited: 5
Association of dietary live microbe intake with diabetic kidney disease in patients with type 2 diabetes mellitus in US adults: a cross-sectional study of NHANES 1999–2018
Min Wang, Zhaohui Huang, Yonghong Zhu, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 6, pp. 705-714
Open Access | Times Cited: 4
Min Wang, Zhaohui Huang, Yonghong Zhu, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 6, pp. 705-714
Open Access | Times Cited: 4
Association between gut microbiota and diabetic nephropathy: a mendelian randomization study
Yongxiu Jin, Chenxi Han, Dongliang Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
Yongxiu Jin, Chenxi Han, Dongliang Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
Gut microbiota profiling reflects the renal dysfunction and psychological distress in patients with diabetic kidney disease
Qi Li, Suyi Xie, Yali Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Qi Li, Suyi Xie, Yali Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4
Mengjiao Xue, Yiwei Tian, Hua Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Mengjiao Xue, Yiwei Tian, Hua Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota
Guoquan Xu, Hai‐Sheng Yuan, Jingran Liu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1470-1470
Open Access
Guoquan Xu, Hai‐Sheng Yuan, Jingran Liu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1470-1470
Open Access
Associations Between Gut Microbiota and Diabetic Nephropathy: A Mendelian Randomization Study
Yujun Xiong, Xingyun Zhu, Hua-Zhao Xu, et al.
Aging Medicine (2025) Vol. 8, Iss. 1
Open Access
Yujun Xiong, Xingyun Zhu, Hua-Zhao Xu, et al.
Aging Medicine (2025) Vol. 8, Iss. 1
Open Access
Exploring the beneficial effect of gut microbiota metabolites on diabetic nephropathy via network pharmacology study
Weiguo Yao, Jinlin Huo, Kun Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Weiguo Yao, Jinlin Huo, Kun Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
Seema Sharma, Nidhi Tiwari, Sampat Singh Tanwar
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Seema Sharma, Nidhi Tiwari, Sampat Singh Tanwar
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The mechanism underlying of Zuoguiyin on liver and kidney in D-gal-induced subacute aging female rats: A perspective on SIRT1-PPARγ pathway regulation of oxidative stress, inflammation and apoptosis
Jichun Xie, Baobao Li, Chao He, et al.
Journal of Ethnopharmacology (2025) Vol. 347, pp. 119811-119811
Closed Access
Jichun Xie, Baobao Li, Chao He, et al.
Journal of Ethnopharmacology (2025) Vol. 347, pp. 119811-119811
Closed Access
Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization
Yipeng Fang, Yunfei Zhang, Qian Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Yipeng Fang, Yunfei Zhang, Qian Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
A multi-omics approach to investigate characteristics of gut microbiota and metabolites in hypertension and diabetic nephropathy SPF rat models
Jinjing Lu, Xiaoying Gong, Chenlu Zhang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Jinjing Lu, Xiaoying Gong, Chenlu Zhang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine
Dan-mai Zhao, Rui Zhong, Xiaotian Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Dan-mai Zhao, Rui Zhong, Xiaotian Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study
Peipei Zhou, Zhenning Hao, Yu Chen, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Peipei Zhou, Zhenning Hao, Yu Chen, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Analysis of the global burden of CKD-T2DM in young and middle-aged adults in 204 countries and territories from 2000 to 2019: A systematic study of the global burden of disease in 2019
Beiyan Liu, Linfeng Li, Huanxi Cui, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111884-111884
Closed Access | Times Cited: 2
Beiyan Liu, Linfeng Li, Huanxi Cui, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111884-111884
Closed Access | Times Cited: 2
Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline
Bo Yi, Ke Su, Yuli Cai, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176905-176905
Closed Access | Times Cited: 1
Bo Yi, Ke Su, Yuli Cai, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176905-176905
Closed Access | Times Cited: 1
Microbiome and type 2 diabetes mellitus: The need-to-know population variability in Latin American populations
Sergio Flores, Mariela Olguín-Barraza, Nelson Maureira-Carsalade, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2024) Vol. 42, Iss. 2, pp. 118-119
Closed Access
Sergio Flores, Mariela Olguín-Barraza, Nelson Maureira-Carsalade, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2024) Vol. 42, Iss. 2, pp. 118-119
Closed Access
Characterization and antibacterial of soybean protein isolate composite film with carvacrol and walnut peel extract
Zhiyong Qin, Meiyi Zou, Kehao Fan, et al.
Journal of Thermoplastic Composite Materials (2024)
Closed Access
Zhiyong Qin, Meiyi Zou, Kehao Fan, et al.
Journal of Thermoplastic Composite Materials (2024)
Closed Access
Identification of renal protective gut microbiome derived-metabolites in diabetic chronic kidney disease: An integrated approach using network pharmacology and molecular docking
G.R. Saranya, Pragasam Viswanathan
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 8, pp. 104028-104028
Open Access
G.R. Saranya, Pragasam Viswanathan
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 8, pp. 104028-104028
Open Access
Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy
Jing Wang, Xiaomin Wang, Tianpeng Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Jing Wang, Xiaomin Wang, Tianpeng Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis
Hongmei Yu, Haitao Tang, Rengui Saxu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Hongmei Yu, Haitao Tang, Rengui Saxu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
